دورية أكاديمية
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial
العنوان: | Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial |
---|---|
المؤلفون: | Hobbs, F. D. Richard, Montgomery, Hugh, Padilla, Francisco, Simón-Campos, Jesus Abraham, Kim, Kenneth, Arbetter, Douglas, Padilla, Kelly W., Reddy, Venkatesh Pilla, Seegobin, Seth, Streicher, Katie, Templeton, Alison, Viani, Rolando M., Johnsson, Eva, Koh, Gavin C. K. W., Esser, Mark T.Aff14, IDs40121023008617_cor15 |
المصدر: | Infectious Diseases and Therapy. :1-19 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 21938229 21936382 |
---|---|
DOI: | 10.1007/s40121-023-00861-7 |